Dimethyl fumarate (DMF), a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor, which has been shown to treat autoimmune diseases, was found to promote oxPPP by increasing G6PD expression in tumor cells. This evidence concerns the gene G6PD and neoplasm.